What does Supernus Pharmaceuticals, Inc. do?

Jun 22 2025 06:34 PM IST
share
Share Via
Supernus Pharmaceuticals, Inc. is a micro-cap pharmaceutical company focused on developing treatments for central nervous system diseases, with recent net sales of $150 million and a net profit of -$12 million. The company has a market cap of approximately $1.81 billion.
Overview:
Supernus Pharmaceuticals, Inc. is a pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases, operating within the Pharmaceuticals & Biotechnology industry and classified as a micro-cap company. Financial Snapshot: Most recent Net Sales: 150 Million (Quarterly Results - Mar 2025) Most recent Net Profit: -12 Million (Quarterly Results - Mar 2025) Market-cap: USD 1,809.86 Million (Micro Cap) Key Metrics: P/E: 29.00 Dividend Yield: 0.00% Debt Equity: -0.44 Return on Equity: 6.24% Price to Book: 1.76 Contact Details: Address: 9715 Key West Avenue, ROCKVILLE MD: 20850 Tel: 1 301 8382500 Website: https://www.supernus.com
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News